|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/397 | (2006.01) |
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 2696869 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12716922.5 |
| Date of filing the European patent application | 2012-04-11 | |
| (97) | Date of publication of the European application | 2014-02-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/033123 |
| Date | 2012-04-11 |
| (87) | Number | WO 2012/142160 |
| Date | 2012-10-18 |
| (30) | Number | Date | Country code |
| 201161474606 P | 2011-04-12 | US |
| (72) |
TAYLOR, Vanessa, US
MASUDA, Esteban, US
|
| (73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
|
| (54) | METHODS FOR INHIBITING ALLOGRAFT REJECTION |
| METHODS FOR INHIBITING ALLOGRAFT REJECTION |